Baseline symptom profile does not predict early response to electroconvulsive therapy (ECT) in major depressive disorder (MDD)

por Bijan Zarrabi, Steve Seiner, Shan Siddiqi
Publicado 2021

PTSD comorbidities in patients undergoing ECT for major depressive disorder: a national study across the United States

por Nagy Youssef, Rikinkumar Patel
Publicado 2021

Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression

por Wei Zheng, Li-Mei Gu, Yan-Ling Zhou, Cheng-Yu Wang, Xiao-Feng Lan, Bin Zhang, Hai-Shan Shi, Dan-Feng Wang, Yu-Ping Ning, Yu-Ping Ning
Publicado 2021

Potential Genetic Overlap Between Insomnia and Sleep Symptoms in Major Depressive Disorder: A Polygenic Risk Score Analysis

por Lindsay M. Melhuish Beaupre, Lindsay M. Melhuish Beaupre, Arun K. Tiwari, Arun K. Tiwari, Vanessa F. Gonçalves, Vanessa F. Gonçalves, Vanessa F. Gonçalves, Clement C. Zai, Clement C. Zai, Clement C. Zai, Clement C. Zai, Victoria S. Marshe, Victoria S. Marshe, Cathryn M. Lewis, Cathryn M. Lewis, Nicholas G. Martin, Andrew M. McIntosh, Mark J. Adams, Bernhard T. Baune, Bernhard T. Baune, Bernhard T. Baune, Doug F. Levinson, Dorret I. Boomsma, Brenda W. J. H. Penninx, Gerome Breen, Gerome Breen, Steve Hamilton, Swapnil Awasthi, Stephan Ripke, Stephan Ripke, Stephan Ripke, Stephan Ripke, Lisa Jones, Ian Jones, Enda M. Byrne, Ian B. Hickie, James P. Potash, Jianxin Shi, Myrna M. Weissman, Myrna M. Weissman, Yuri Milaneschi, Stanley I. Shyn, Eco J. C. de Geus, Gonneke Willemsen, Gregory M. Brown, Gregory M. Brown, James L. Kennedy, James L. Kennedy, James L. Kennedy, Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium
Publicado 2021

Associations Between Tenascin-C and Testosterone Deficiency in Men with Major Depressive Disorder: A Cross-Sectional Retrospective Study

por Peng R, Li Y
Publicado 2021

Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder

por McIntyre RS, Loft H, Christensen MC
Publicado 2021

Is Agomelatine Associated with Less Sedative-Hypnotic Usage in Patients with Major Depressive Disorder? A Nationwide, Population-Based Study

por Hsing SC, Jin YT, Tzeng NS, Chung CH, Chen TY, Chang HA, Kao YC, Chien WC
Publicado 2020

Impact of Expression and Genetic Variation of microRNA-34b/c on Cognitive Dysfunction in Patients with Major Depressive Disorder

por Sun N, Yang C, He X, Liu Z, Liu S, Li X, Wang Y, Jin R, Zhang K
Publicado 2020

Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population

por Wang F, Yu S, Zhou R, Mao R, Zhao G, Guo X, Xu Q, Chen J, Zhang C, Fang Y
Publicado 2020

Reproducibility of automated habenula segmentation via deep learning in major depressive disorder and normal controls with 7 Tesla MRI

por Sang-Heon Lim, Jihyun Yoon, Young Jae Kim, Chang-Ki Kang, Seo-Eun Cho, Kwang Gi Kim, Seung-Gul Kang
Publicado 2021

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies

por Thase ME, Weiller E, Zhang P, Weiss C, McIntyre RS
Publicado 2018

The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials

por Li G, Wang X, Ma D
Publicado 2016

Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes.

por Glen I Spielmans, Margit I Berman, Eftihia Linardatos, Nicholas Z Rosenlicht, Angela Perry, Alexander C Tsai
Publicado 2013

Classification of different therapeutic responses of major depressive disorder with multivariate pattern analysis method based on structural MR scans.

por Feng Liu, Wenbin Guo, Dengmiao Yu, Qing Gao, Keming Gao, Zhimin Xue, Handan Du, Jianwei Zhang, Changlian Tan, Zhening Liu, Jingping Zhao, Huafu Chen
Publicado 2012

Structural MRI at 7T reveals amygdala nuclei and hippocampal subfield volumetric association with Major Depressive Disorder symptom severity

por S. S. G. Brown, J. W. Rutland, G. Verma, R. E. Feldman, J. Alper, M. Schneider, B. N. Delman, J. M. Murrough, P. Balchandani
Publicado 2019

Case-control association study of ABCB1 gene and major depressive disorder in a local Chinese Han population

por Xie WW, Zhang L, Wu RR, Yu Y, Zhao JP, Li LH
Publicado 2015

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder

por Jha MK, Teer RB, Minhajuddin A, Greer TL, Rush AJ, Trivedi MH
Publicado 2017

Subcortical volume and white matter integrity abnormalities in major depressive disorder: findings from UK Biobank imaging data

por Xueyi Shen, Lianne M. Reus, Simon R. Cox, Mark J. Adams, David C. Liewald, Mark E. Bastin, Daniel J. Smith, Ian J. Deary, Heather C. Whalley, Andrew M. McIntosh
Publicado 2017

Twelve-month, prospective, open-label study of repetitive transcranial magnetic stimulation for major depressive disorder in partial remission

por Charnsil C, Suttajit S, Boonyanaruthee V, Leelarphat S
Publicado 2012

The structural equation analysis of childhood abuse, adult stressful life events, and temperaments in major depressive disorders and their influence on refractoriness

por Toda H, Inoue T, Tsunoda T, Nakai Y, Tanichi M, Tanaka T, Hashimoto N, Nakato Y, Nakagawa S, Kitaichi Y, Mitsui N, Boku S, Tanabe H, Nibuya M, Yoshino A, Kusumi I
Publicado 2015